Heritable pulmonary arterial hypertension – Basic Information

Go back

Heritable pulmonary arterial hypertension is a rare genetic condition that causes dangerously high blood pressure in the arteries connecting the heart to the lungs, making it increasingly difficult for the heart to pump blood and for the body to receive enough oxygen.

Understanding Heritable Pulmonary Arterial Hypertension

Heritable pulmonary arterial hypertension, sometimes called familial pulmonary arterial hypertension, is a form of pulmonary arterial hypertension (PAH) that occurs when gene changes are passed down from parent to child. This condition affects the small blood vessels in the lungs, causing them to become narrow, blocked, or damaged. When this happens, blood cannot flow through the lungs as easily as it should, and pressure builds up in the pulmonary arteries—the vessels that carry oxygen-poor blood from the heart to the lungs.[1][2]

What makes this condition “heritable” is that it stems from genetic variants inherited from a parent. This is true whether or not there is a known family history of PAH. The term applies both when PAH occurs in two or more family members and when it appears as a single case in a family, as long as a disease-causing genetic change has been identified in one of the known genes.[1][12]

This disease is progressive, meaning it gets worse over time. As the blood vessels in the lungs become more resistant to blood flow, the right side of the heart must work harder to push blood through. Eventually, this extra strain weakens the heart muscle, which can lead to right-sided heart failure—a serious condition where the heart can no longer pump effectively. Without treatment, heritable pulmonary arterial hypertension can be life-threatening.[4][11]

⚠️ Important
Heritable pulmonary arterial hypertension is different from regular high blood pressure that affects arteries throughout the body. It specifically targets the arteries in the lungs and puts pressure on the right side of the heart. This is why it requires specialized diagnosis and treatment from doctors who understand lung and heart conditions.

How Common Is Heritable Pulmonary Arterial Hypertension?

Heritable pulmonary arterial hypertension is an extremely rare condition. It represents less than 4% of all pulmonary arterial hypertension cases. When looking at the broader category of PAH, about 500 to 1,000 people are diagnosed each year in the United States. In Western countries, roughly 25 per 1 million people are living with PAH of all types.[4][11]

The prevalence of heritable PAH specifically is estimated at less than 1 per million people, making it one of the rarer genetic conditions affecting the heart and lungs.[4]

When it comes to who develops heritable pulmonary arterial hypertension, certain patterns emerge. The disease usually develops in adults, although it can rarely affect children. The average age at diagnosis is around 35 years. Women are twice as likely as men to be affected by this condition. When men do develop heritable PAH, particularly those over age 65, they are more likely to have severe cases.[2][4][10]

Patients with heritable pulmonary arterial hypertension often have a more severe clinical presentation compared to those with other forms of PAH. They tend to have less response to certain medications used in testing, lower cardiac index (a measurement of how well the heart pumps blood), and higher resistance in the blood vessels of the lungs.[4]

What Causes Heritable Pulmonary Arterial Hypertension?

The root cause of heritable pulmonary arterial hypertension lies in genetic mutations—changes in the DNA instructions that tell cells how to function properly. These genetic changes are passed from parents to children, which is why the condition runs in families. However, it’s important to understand that not everyone who inherits a disease-causing gene change will develop the condition.[2][7]

The most common genetic cause of heritable PAH is a mutation in a gene called BMPR2. This gene plays a role in controlling how many cells grow in certain tissues. When there’s a mutation in BMPR2, it can promote excessive cell growth or prevent cell death in the small arteries of the lungs. As a result, these arteries become overgrown with cells, which makes them narrower. The narrowing increases resistance to blood flow, forcing the heart to work harder to push blood through the lungs.[4][7]

While BMPR2 gene mutations are the most common cause, researchers have identified several other genes that can also lead to heritable pulmonary arterial hypertension, though these are much less frequent. These include genes named ACVRL1, KCNK3, CAV1, TBX4, and SMAD9. Mutations in ACVRL1 or TBX4 are particularly concerning because they tend to occur more commonly in children and often lead to rapid disease progression with poor outcomes.[4][7]

The pattern of inheritance for heritable pulmonary arterial hypertension is called autosomal dominant, which means only one copy of a mutated gene from one parent is enough to cause the disease. However, the condition has what doctors call “incomplete penetrance.” This means that even if someone inherits the genetic mutation, they may never develop symptoms. For BMPR2 mutations specifically, penetrance is estimated at about 42% in women who carry the mutation and 14% in men who carry it. In other words, less than half of female mutation carriers and only about one in seven male carriers will actually develop the disease.[4][7]

Risk Factors for Developing the Condition

The primary risk factor for heritable pulmonary arterial hypertension is having a family history of PAH or carrying a genetic mutation in one of the known disease-causing genes. If a parent has heritable PAH or carries a mutation in genes like BMPR2, their children have a 50% chance of inheriting that genetic change. However, as mentioned earlier, inheriting the mutation doesn’t guarantee that the person will develop the disease.[2][7]

Being female increases the likelihood of developing heritable pulmonary arterial hypertension if you carry a genetic mutation. Women with disease-causing mutations are about three times more likely than men to actually develop symptoms and be diagnosed with the condition.[2][4]

While the genetic component is the defining feature of heritable PAH, it’s worth noting that other factors can sometimes influence whether someone with a genetic predisposition develops the disease. These may include environmental triggers or additional genetic variations that modify disease risk, though research in this area is still ongoing.[7]

It’s also important to distinguish heritable PAH from other forms of pulmonary arterial hypertension that might have different risk factors. Some people develop PAH in connection with other medical conditions such as connective tissue diseases like lupus or scleroderma, HIV infection, liver disease with portal hypertension, congenital heart disease, or after using certain drugs or toxins. When PAH occurs with no identifiable cause and no genetic mutation is found, it’s called “idiopathic” pulmonary arterial hypertension.[6][11]

Recognizing the Symptoms

One of the challenges with heritable pulmonary arterial hypertension is that symptoms often develop very slowly and may not be noticeable in the early stages of the disease. You might not realize anything is wrong until the condition has progressed significantly. This delay in recognizing symptoms is one reason why diagnosis is often delayed—on average, it takes about 27 months from when symptoms first appear to when a person receives a diagnosis.[2][13]

The most common symptom is shortness of breath, medically called dyspnea. At first, this breathlessness usually happens only during physical activity like climbing stairs, walking quickly, or exercising. As the disease progresses, shortness of breath may occur even when you’re resting. You might notice that activities you used to do easily now leave you feeling winded and exhausted.[2][3][10]

Fatigue is another extremely common symptom. People with heritable PAH often feel tired and lack energy, even after getting adequate rest. This happens because the heart isn’t pumping blood efficiently enough to deliver oxygen to the body’s tissues and organs.[2][10]

Some people experience chest pain or pressure. This discomfort may feel similar to the sensation of having something heavy on your chest. Others describe palpitations—the feeling that your heart is racing, pounding, or beating irregularly. This occurs because the heart is working harder to compensate for the increased resistance in the pulmonary arteries.[2][3][10]

Dizziness and fainting spells, known as syncope, are warning signs that should never be ignored. These symptoms happen when the heart cannot pump enough oxygen-rich blood to the brain. Fainting is one of the most common symptoms of pulmonary arterial hypertension and indicates that the condition is affecting your body’s ability to function normally.[2][3][10]

As heritable pulmonary arterial hypertension advances, you may notice swelling, called edema, in your feet, ankles, and legs. Over time, this swelling can extend to your abdomen and even your neck. This happens when the right side of the heart becomes so weakened that fluid backs up into the body’s tissues.[2][3][10]

Some people develop blue or gray discoloration of the skin, particularly in the fingers or lips. This is called cyanosis and indicates that the blood isn’t carrying enough oxygen. The appearance of this symptom varies depending on your natural skin tone, but it generally indicates a more serious stage of the disease.[3][11]

Less commonly, people with heritable PAH may experience other symptoms such as a racing or pounding heartbeat that’s noticeable even at rest, or in rare cases, coughing up blood (hemoptysis). Some people, particularly women, may develop Raynaud phenomenon, where fingers and toes become cold and change color in response to cold temperatures or stress. Very rarely, clubbing—a change in the shape of fingers and toes—has been observed.[4]

⚠️ Important
The symptoms of heritable pulmonary arterial hypertension often resemble those of other, more common heart and lung conditions. This similarity is one reason the condition can be hard to diagnose. If you experience progressive shortness of breath, especially if you have a family history of PAH or genetic mutations, it’s crucial to seek medical evaluation. Early diagnosis and treatment can significantly improve outcomes.

Prevention and Early Detection

Because heritable pulmonary arterial hypertension is caused by genetic mutations that are present from birth, there is no way to prevent the condition entirely. However, if you have a family history of PAH or know that you carry a genetic mutation associated with the disease, there are important steps you can take for early detection and management.[2][4]

Genetic testing and counseling are valuable tools for families affected by heritable PAH. If you have been diagnosed with PAH, your doctor may recommend genetic testing to see if you carry mutations in BMPR2 or other PAH-associated genes. If a mutation is found, other family members can be tested to see if they also carry the genetic change. This information helps identify who may be at risk, even before symptoms develop.[2][4]

For people who are known to carry PAH-causing genetic mutations but don’t yet have symptoms, regular screening and monitoring are recommended. This typically involves periodic medical evaluations that may include tests like echocardiograms to check for early signs of increased pressure in the pulmonary arteries. Catching the disease at an earlier stage allows for earlier intervention, which can slow disease progression and improve quality of life.[2][4]

If you have a family history of heritable PAH or carry a known genetic mutation, it’s important to be vigilant about any new symptoms, particularly progressive shortness of breath or unusual fatigue. Seeking medical attention promptly when symptoms first appear can lead to earlier diagnosis and treatment.[2]

For couples who both carry or are affected by heritable PAH and are planning to have children, specialized reproductive options exist. These include prenatal genetic testing during pregnancy and preimplantation genetic diagnosis, which involves testing embryos created through in vitro fertilization before pregnancy is established. These options can help families make informed decisions about family planning.[4]

Beyond genetic factors, there are general health measures that are important for anyone at risk for pulmonary arterial hypertension. These include avoiding exposure to certain drugs and substances known to cause PAH, such as methamphetamines and cocaine. Maintaining overall cardiovascular health through a balanced diet and appropriate levels of physical activity can also support lung and heart function, though any exercise program should be discussed with your healthcare provider.[6][11]

How the Disease Affects the Body

Understanding the physical changes that occur in heritable pulmonary arterial hypertension helps explain why symptoms develop and why the condition is so serious. The disease fundamentally alters how blood flows through the lungs and places enormous stress on the heart.[3][11]

In a healthy person, blood flows easily through small arteries in the lungs called pulmonary arteries. The right side of the heart pumps oxygen-poor blood through these arteries to the lungs, where the blood picks up fresh oxygen. The oxygen-rich blood then travels to the left side of the heart, which pumps it out to the rest of the body. This system works smoothly because the pulmonary arteries are flexible and wide enough to allow blood to flow with minimal resistance.[3]

In heritable pulmonary arterial hypertension, damage occurs to the inner lining of the blood vessels in the lungs. Genetic mutations cause cells in the walls of the pulmonary arteries to multiply excessively or fail to die when they should. As these cells accumulate, the walls of the blood vessels become thick and the space inside the vessels becomes narrow. In some cases, the vessels may become completely blocked or destroyed.[3][7]

When the pulmonary arteries narrow or become blocked, blood has a much harder time flowing through the lungs. Imagine trying to push water through a partially clogged pipe—it requires much more force. The same thing happens in the lungs. To overcome this increased resistance, blood pressure in the pulmonary arteries rises significantly. Normal mean pulmonary artery pressure is about 15 mm Hg, but in people with PAH, it exceeds 20 mm Hg at rest.[2][13]

The right ventricle—the chamber of the heart responsible for pumping blood to the lungs—must work much harder to push blood through the narrowed, resistant arteries. At first, the heart muscle compensates by becoming thicker and stronger, similar to how a weightlifter’s muscles grow with exercise. However, unlike exercise that strengthens the body, this stress on the heart is harmful.[11]

Over time, the constant extra work exhausts the right ventricle. The heart muscle becomes progressively weaker and less efficient at pumping blood. Eventually, this leads to right-sided heart failure, where the right ventricle can no longer pump blood effectively. When this happens, blood backs up in the veins, causing fluid to leak into body tissues, which produces the swelling seen in the legs, abdomen, and other areas.[3][11]

The problems don’t stop with the heart and lungs. Because the narrowed pulmonary arteries restrict blood flow, less blood can pass through the lungs to pick up oxygen. As a result, less oxygen-rich blood is available to be pumped to the rest of the body. Organs and tissues throughout the body—including the brain, muscles, and other vital organs—receive insufficient oxygen to function properly. This oxygen deprivation causes many of the symptoms people experience, such as fatigue, shortness of breath, and dizziness.[11]

The progression of these physical changes explains why heritable pulmonary arterial hypertension gets worse over time if left untreated. The narrowing of blood vessels continues, pressure continues to rise, and the heart continues to weaken. This cascade of problems is why early diagnosis and treatment are so crucial—interventions can help slow these harmful processes and preserve heart and lung function for as long as possible.[4][11]

Ongoing Clinical Trials on Heritable pulmonary arterial hypertension

  • Study on Sotatercept for Improving Heart Function in Patients with Pulmonary Arterial Hypertension

    Recruiting

    1 1 1 1
    Investigated drugs:
    The Netherlands
  • Study on Dapagliflozin for Patients with Pulmonary Arterial Hypertension to Improve Exercise Capacity and Heart Function

    Not recruiting

    1 1
    Investigated drugs:
    Denmark

References

https://phassociation.org/patients/aboutph/genetic-pah/

https://www.ncbi.nlm.nih.gov/books/NBK1485/

https://www.mayoclinic.org/diseases-conditions/pulmonary-hypertension/symptoms-causes/syc-20350697

https://www.orpha.net/en/disease/detail/275777

https://www.lung.org/lung-health-diseases/lung-disease-lookup/pulmonary-arterial-hypertension/learn-about-pulmonary-arterial-hypertension

https://my.clevelandclinic.org/health/diseases/23913-pulmonary-arterial-hypertension

https://medlineplus.gov/genetics/condition/pulmonary-arterial-hypertension/

https://globalgenes.org/subtype/heritable-pulmonary-arterial-hypertension/

https://www.mayoclinic.org/diseases-conditions/pulmonary-hypertension/diagnosis-treatment/drc-20350702

https://www.ncbi.nlm.nih.gov/books/NBK1485/

https://my.clevelandclinic.org/health/diseases/23913-pulmonary-arterial-hypertension

https://phassociation.org/patients/aboutph/genetic-pah/

https://www.aafp.org/pubs/afp/issues/2010/0815/p370.html

https://www.mayoclinic.org/diseases-conditions/pulmonary-hypertension/diagnosis-treatment/drc-20350702

https://chroniclungdiseases.com/en/news/living-with-pulmonary-hypertension/

https://lungfoundation.com.au/support-resources/resource-hub/living-with-pulmonary-arterial-hypertension-booklet/

https://my.clevelandclinic.org/health/diseases/23913-pulmonary-arterial-hypertension

https://share.upmc.com/2022/08/life-with-pulmonary-hypertension/

https://phassociation.org/newly-diagnosed/faq/

https://www.myphteam.com/resources/living-with-pulmonary-arterial-hypertension-life-hacks-for-everyday-help

https://www.webmd.com/lung/pulmonary-arterial-hypertension

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.nibib.nih.gov/science-education/science-topics/rapid-diagnostics

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

https://www.roche.com/stories/terminology-in-diagnostics

FAQ

If my parent has heritable pulmonary arterial hypertension, will I definitely get it too?

Not necessarily. While you have a 50% chance of inheriting the genetic mutation if your parent carries it, having the mutation doesn’t guarantee you’ll develop the disease. For the most common genetic cause (BMPR2 mutations), only about 42% of women and 14% of men who carry the mutation actually develop symptoms. However, genetic testing and regular monitoring are recommended for family members of people with heritable PAH.

Is heritable pulmonary arterial hypertension the same as regular high blood pressure?

No, they are completely different conditions. Regular high blood pressure (hypertension) affects arteries throughout your body. Heritable pulmonary arterial hypertension specifically affects only the arteries in your lungs and puts strain on the right side of your heart. It cannot be treated with typical blood pressure medications and requires specialized care from pulmonary hypertension specialists.

Why does heritable PAH affect women more than men?

Women are about twice as likely as men to develop heritable pulmonary arterial hypertension, even when both carry the same genetic mutations. The exact reasons aren’t fully understood, but it may involve hormonal factors or differences in how male and female bodies respond to the genetic changes. However, when men do develop the disease, particularly older men, they often have more severe cases.

Can heritable PAH be cured?

Currently, there is no cure for heritable pulmonary arterial hypertension. However, treatments are available that can significantly improve symptoms, slow disease progression, and extend life expectancy. Early diagnosis and consistent treatment are essential for the best possible outcomes.

What does genetic testing for heritable PAH involve?

Genetic testing for heritable PAH typically starts with a blood test. Doctors first test for mutations in the BMPR2 gene since it’s the most common cause. If no BMPR2 mutation is found but there’s a strong family history of PAH, testing may continue for other genes like ACVRL1, KCNK3, CAV1, TBX4, and SMAD9. The results help determine if family members should be monitored and guide treatment decisions.

🎯 Key takeaways

  • Heritable pulmonary arterial hypertension is an extremely rare genetic condition affecting less than 1 in a million people, caused primarily by mutations in the BMPR2 gene.
  • Women are twice as likely to develop the disease as men, even when carrying the same genetic mutations, though the reasons remain not fully understood.
  • The condition causes blood vessels in the lungs to narrow dramatically, forcing the right side of the heart to work harder until it eventually weakens and fails.
  • Early symptoms like breathlessness during exercise often go unrecognized for years, with diagnosis typically delayed by more than two years from symptom onset.
  • Inheriting a disease-causing gene doesn’t guarantee you’ll develop symptoms—less than half of female mutation carriers and only 14% of male carriers actually develop the disease.
  • People with heritable PAH typically face more severe disease with poorer response to certain treatments compared to those with other forms of pulmonary arterial hypertension.
  • Genetic testing can identify at-risk family members before symptoms appear, allowing for early monitoring and potentially life-saving early intervention.
  • The average age at diagnosis is around 35 years, but the condition can affect people of all ages from infancy through elderly years.

Connected medications: